P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes

Bibliographic Details
Main Authors:	Morgado MG, Bello G, Côrtes FH
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.
by: Zabrina L Brumme, et al.
Published: (2009-08-01)

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
by: Brumme, Zabrina L., et al.
Published: (2010)

HIV-1 subtype B- and F1-infected subjects display higher cross-clade T-Cell response than subtype C-infected subjects
by: Côrtes FH, et al.
Published: (2012-09-01)

Functional association between the nef gene product and gag-pol region of HIV-1.
by: Ono, Takeshi
Published: (2014)

Characterization of HIV-1 <it>gag</it> and <it>nef</it> in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
by: Tongo Marcel, et al.
Published: (2013-01-01)

The characterisation and expression of HIV-1 subtype C gag
by: Sampson, Candice Corene
Published: (2012)

Diversity of GAG Gene Sequence Encoding Immunodominant Epitope on Capsid Protein of Lentiviruses from Sheep in Poland
by: Olech Monika, et al.
Published: (2012-12-01)

Characterisation of nef from HIV-1 subtype c-infected individuals
by: Mashishi., Tumelo. Nkoenyana.
Published: (2019)

P20-12. Heterogeneity of Gag mutational pathways in primary HIV-1 subtype C infection
by: Makhema J, et al.
Published: (2009-10-01)

N-myristoyltransferase1 and N-myristoyltransferase2 Exhibit Differential Substrate Specificity for HIV-Gag and HIV-Nef
by: Smith Charles, et al.
Published: (2005-12-01)

Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein.
by: Valentine U Chukwuma, et al.
Published: (2015-01-01)

HIV-1 subtype A gag variability and epitope evolution.
by: Syed Hani Abidi, et al.
Published: (2014-01-01)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
by: Kathryn L Hopkins, et al.
Published: (2014-01-01)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
by: Gloria Omosa-Manyonyi, et al.
Published: (2015-01-01)

CD8(+) T cell cross-reactivity profiles and HIV-1 immune escape towards an HLA-B35-restricted immunodominant Nef epitope.
by: Chihiro Motozono, et al.
Published: (2013-01-01)

Polymorphism of the Human Immunodeficiency Virus Type 1 in Brazil: Genetic Characterization of the nef Gene and Implications for Vaccine Design
by: ML Guimarães, et al.
Published: (2002-06-01)

CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: Use of multiple peptide sets increases the detectable breadth of the CTL response
by: Birx Deborah L, et al.
Published: (2006-04-01)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
by: Kaleebu P, et al.
Published: (2009-10-01)

Homogenous HIV-1 subtype B from the Brazilian Amazon with infrequent diverse BF1 recombinants, subtypes F1 and C among blood donors.
by: Myuki Alfaia Esashika Crispim, et al.
Published: (2019-01-01)

Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
by: Matilda Chelimo Saina, et al.
Published: (2015-01-01)

Reatividade de linfócitos T de indivíduos infectados pelo HIV-1 contra epitopos GAG e NEF de diferentes subtipos HIV-1
by: Coutinho Junior, Raimundo
Published: (2012)

Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge.
by: Arun K Sasikala-Appukuttan, et al.
Published: (2013-01-01)

No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.
by: Denis R Chopera, et al.
Published: (2013-01-01)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
by: Zembe L, et al.
Published: (2012-09-01)

HIV-1 Nef: at the crossroads
by: Garcia J Victor, et al.
Published: (2008-09-01)

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load.
by: Holly Janes, et al.
Published: (2012-01-01)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
by: Wagner R, et al.
Published: (2009-10-01)

Construction and evaluation of three candidate vaccines expressing HIV-1 subtype-C mosaic Gag
by: Jongwe, Tsungai Ivai
Published: (2016)

Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection.
by: Vladimir Novitsky, et al.
Published: (2009-11-01)

Avaliação da resposta de células T frente aos peptídeos de GAG e NEF do HIV-1 e de parâmetros imunológicos e genéticos associados ao controle da replicação viral
by: Côrtes, Fernanda Heloise
Published: (2016)

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
by: Gagro Alenka, et al.
Published: (2005-12-01)

The Nef activity on HIV-1 infectivity
by: Stéphane eBasmaciogullari, et al.
Published: (2014-05-01)

T-cell epitopes identified by BALB/c mice immunized with vaccinia expressing HIV-1 gag lie within immunodominant regions recognized by HIV-infected Indian patients
by: Ashwini V Shete, et al.
Published: (2011-01-01)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with <it>gag</it>, <it>tat</it>, <it>rev</it> and <it>nef</it> mRNA
by: Nijs Griet, et al.
Published: (2011-10-01)

A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities.
by: Marta Martínez-Bonet, et al.
Published: (2015-01-01)

Expression of HIV-1 subtype C nef in E. coli and Nicotiana benthamiana : development of plant-based vaccines for HIV
by: Bandawe, Gama
Published: (2014)

Accessory gene components for an HIV-1 subtype C vaccine : functional analysis of mutated Tat, Rev and Nef antigens
by: Scriba, Thomas Jens
Published: (2012)

Close phylogenetic relationship between Angolan and Romanian HIV-1 subtype F1 isolates
by: Serrano Ducelina, et al.
Published: (2009-04-01)

A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors
by: Dibya Ghimire, et al.
Published: (2021-04-01)

TNF and HIV-1 Nef: An Intimate Interplay
by: Georges Herbein
Published: (2016-11-01)